Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GeneDx Holdings Corp. (WGS : NSDQ)

• Company Description    GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. Number of Employees: 1,000

• Price / Volume Information    Yesterday's Closing Price: $123.95 Daily Weekly Monthly 20 Day Moving Average: 597,576 shares Shares Outstanding: 28.73 (millions) Market Capitalization: $3,560.59 (millions) Beta: 2.04 52 Week High: $136.00 52 Week Low: $35.88 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.87% -0.90% 12 Week 92.38% 74.75% Year To Date 61.27% 46.24%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 333 Ludlow Street North Tower 6th Floor - Stamford,CT 06902 USA ph: 888-729-1206 fax: - investors@genedx.com http://www.genedx.com

• General Corporate Information    Officers Katherine Stueland - Chief Executive Officer and Director Jason Ryan - Chairman Kevin Feeley - Chief Financial Officer Eli D. Casdin - Director Emily Leproust - Director Peer Information GeneDx Holdings Corp. (CHCR) GeneDx Holdings Corp. (ESRX) GeneDx Holdings Corp. (MYDP) GeneDx Holdings Corp. (COR) GeneDx Holdings Corp. (GBCS) GeneDx Holdings Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 81663L200 SIC: 8000 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/04/25 Share - Related Items Shares Outstanding: 28.73 Most Recent Split Date: 5.00 (0.03:1) Beta: 2.04 Market Capitalization: $3,560.59 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.33 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $1.21 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/25

• Fundamental Ratios P/E Current FY Estimate: 102.44 Trailing 12 Months: 81.55 PEG Ratio: - Price Ratios Price/Book: 12.85 Price/Cash Flow: 121.13 Price / Sales: 9.83 EPS Growth vs. Year Ago Period: 554.55% vs. Previous Quarter: 78.57% Sales Growth vs. Year Ago Period: 45.63% vs. Previous Quarter: 17.88% ROE 06/30/25 - 16.51 03/31/25 - 10.17 12/31/24 - 3.16 ROA 06/30/25 - 9.35 03/31/25 - 5.51 12/31/24 - 1.67 Current Ratio 06/30/25 - 2.87 03/31/25 - 3.25 12/31/24 - 3.61 Quick Ratio 06/30/25 - 2.70 03/31/25 - 3.07 12/31/24 - 3.42 Operating Margin 06/30/25 - 11.21 03/31/25 - 6.94 12/31/24 - 2.20 Net Margin 06/30/25 - 0.39 03/31/25 - -11.69 12/31/24 - -17.12 Pre-Tax Margin 06/30/25 - 0.42 03/31/25 - -11.63 12/31/24 - -17.23 Book Value 06/30/25 - 9.65 03/31/25 - 9.02 12/31/24 - 8.75 Inventory Turnover 06/30/25 - 10.34 03/31/25 - 10.33 12/31/24 - 10.24 Debt-to-Equity 06/30/25 - 0.19 03/31/25 - 0.20 12/31/24 - 0.21 Debt-to-Capital 06/30/25 - 15.72 03/31/25 - 16.75 12/31/24 - 17.47

Powered by Zacks Investment Research ©